首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Diagnostic value of strand‐specific miRNA‐101‐3p and miRNA‐101‐5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action
【2h】

Diagnostic value of strand‐specific miRNA‐101‐3p and miRNA‐101‐5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action

机译:链特异性miRNA‐101‐3p和miRNA‐101‐5p对肝细胞癌的诊断价值及其可能作用机制的生物信息学分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There is accumulating evidence that miRNA might serve as potential diagnostic and prognostic markers for various types of cancer. Hepatocellular carcinoma (HCC) is the most common type of malignant lesion but the significance of miRNAs in HCC remains largely unknown. The present study aimed to establish the diagnostic value of miR‐101‐3p/5p in HCC and then further investigate the prospective molecular mechanism via a bioinformatic analysis. First, the miR‐101 expression profiles and parallel clinical parameters from 362 HCC patients and 50 adjacent non‐HCC tissue samples were downloaded from The Cancer Genome Atlas (TCGA). Second, we aggregated all miR‐101‐3p/5p expression profiles collected from published literature and the Gene Expression Omnibus and TCGA databases. Subsequently, target genes of miR‐101‐3p and miR‐101‐5p were predicted by using the miRWalk database and then overlapped with the differentially expressed genes of HCC identified by natural language processing. Finally, bioinformatic analyses were conducted with the overlapping genes. The level of miR‐101 was significantly lower in HCC tissues compared with adjacent non‐HCC tissues (P < 0.001), and the area under the curve of the low miR‐101 level for HCC diagnosis was 0.925 (P < 0.001). The pooled summary receiver operator characteristic (SROC) of miR‐101‐3p was 0.86, and the combined SROC curve of miR‐101‐5p was 0.80. Bioinformatic analysis showed that the target genes of both miR‐101‐3p and miR‐101‐5p are involved in several pathways that are associated with HCC. The hub genes for miR‐101‐3p and miR‐101‐5p were also found. Our results suggested that both miR‐101‐3p and miR‐101‐5p might be potential diagnostic markers in HCC, and that they exert their functions via targeting various prospective genes in the same pathways.
机译:越来越多的证据表明,miRNA可能充当各种类型癌症的潜在诊断和预后标志物。肝细胞癌(HCC)是最常见的恶性病变类型,但miRNA在HCC中的意义仍然未知。本研究旨在确定miR‐101‐3p / 5p在肝癌中的诊断价值,然后通过生物信息学分析进一步研究前瞻性分子机制。首先,从The Cancer Genome Atlas(TCGA)下载了362例HCC患者和50个相邻的非HCC组织样品的miR-101表达谱和平行的临床参数。其次,我们汇总了从已发表的文献以及Gene Expression Omnibus和TCGA数据库收集的所有miR-101-3p / 5p表达谱。随后,使用miRWalk数据库预测了miR‐101-3p和miR‐101-5p的目标基因,然后与通过自然语言处理鉴定的HCC差异表达基因重叠。最后,对重叠的基因进行了生物信息学分析。与相邻的非HCC组织相比,HCC组织中的miR-101水平显着降低(P <0.001),低miR-101水平曲线对HCC诊断的面积为0.925(P <0.001)。 miR-101-3p的汇总汇总接收器操作员特征(SROC)为0.86,miR-101-5p的组合SROC曲线为0.80。生物信息学分析表明,miR‐101-3p和miR‐101-5p的靶基因均参与了与HCC相关的几种途径。还发现了miR‐101-3p和miR‐101-5p的中枢基因。我们的结果表明,miR-101-3p和miR-101-5p可能是肝癌的潜在诊断标志物,它们通过靶向同一途径中的各种前瞻性基因来发挥其功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号